Vitali Sintchenko Selected Research

Neurotoxins

9/2015

Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vitali Sintchenko Research Topics

Disease

18	Whooping Cough (Pertussis) 12/2023 - 06/2009
15	Infections 04/2024 - 07/2005
5	Tuberculosis (Tuberculoses) 10/2019 - 04/2010
4	COVID-19 05/2023 - 09/2020
3	Communicable Diseases (Infectious Diseases) 12/2023 - 01/2004
3	Pneumococcal Infections 11/2023 - 11/2018
3	Coinfection 01/2022 - 11/2015
3	Human Influenza (Influenza) 12/2020 - 09/2009
2	Sepsis (Septicemia) 11/2023 - 01/2011
2	Reinfection 12/2021 - 01/2018
2	Pneumonia (Pneumonitis) 10/2020 - 07/2007
2	Pulmonary Tuberculosis 03/2020 - 10/2019
1	Extensively Drug-Resistant Tuberculosis 12/2023
1	Pseudomonas Infections 10/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Salmonella Infections (Salmonellosis) 12/2020
1	Botulism 09/2015
1	Bacillary Dysentery (Shigellosis) 08/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2011
1	Ventilator-Associated Pneumonia 01/2006

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 12/2023 - 01/2011
5	Acellular VaccinesIBA 12/2023 - 06/2009
4	Virulence Factors (Pathogenicity Factors)IBA 04/2024 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 07/2005
4	AntigensIBA 01/2021 - 01/2011
4	pertactin FDA Link 01/2020 - 04/2014
3	MacrolidesIBA 12/2023 - 12/2020
2	Antiviral Agents (Antivirals)IBA 05/2023 - 09/2009
2	AntibodiesIBA 01/2021 - 09/2020
2	Nucleic AcidsIBA 09/2020 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2018
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011 - 04/2010
1	AzolesIBA 11/2023
1	SolutionsIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	23S Ribosomal RNAIBA 10/2022
1	Erythromycin (Erycette)FDA LinkGeneric 10/2022
1	Subgenomic RNAIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	NucleotidesIBA 12/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	beta-LactamsIBA 12/2020
1	Conjugate VaccinesIBA 10/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Immunoglobulin G (IgG)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	AcidsIBA 03/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Pertussis ToxinIBA 01/2020
1	Methionine (L-Methionine)FDA Link 10/2019
1	AminopeptidasesIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 10/2019
1	IronIBA 12/2018
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 12/2018
1	Fimbriae Proteins (Pilin)IBA 12/2018
1	ChlorhexidineIBA 11/2018
1	Sulfates (Sulfates, Inorganic)IBA 01/2018
1	NeurotoxinsIBA 09/2015
1	incobotulinumtoxinA FDA Link 09/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 08/2015
1	FluoroquinolonesIBA 09/2014
1	Iron Chelating AgentsIBA 02/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2012
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2010
1	OligonucleotidesIBA 04/2010
1	Complement System Proteins (Complement)IBA 07/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2009
1	Drug Therapy (Chemotherapy) 12/2023
1	Incubators 01/2022
1	Operative Surgical Procedures 12/2018
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2018
1	Retreatment 01/2017
1	Intravesical Administration 01/2011
1	Immunotherapy 01/2011
1	Critical Care (Surgical Intensive Care) 01/2004